In order to evaluate Fas and Bcl-2 expressions in CD14+ monocytes, to measure soluble CD14 serum levels and to analyze the relationships with lupus nephritis and disease activity, we enrolled 41 patients with juvenile systemic lupus erythematosus (JSLE) and 27 healthy volunteers. Disease activity was determined by SLEDAI score. Peripheral monocytes were stained for CD14, Fas and Bcl-2 molecules, and cellular expressions were determined by flow cytometry. Soluble CD14 levels were measured by a quantitative ELISA kit. JSLE patients, those with active disease and those with nephritis, presented significantly reduced expressions of Fas and Bcl-2 proteins in CD14+ monocytes compared with healthy controls. Significant inverse correlations between percentages of CD14+Fas+ cells, SLEDAI score and anti-dsDNA antibodies were observed. JSLE patients had soluble CD14 levels similar to controls, although sCD14 levels positively correlated with ESR, but not with SLEDAI score. JSLE patients with nephritis also presented sCD14 levels similar to controls. In conclusion, the reduced expressions of Fas and Bcl-2 proteins in CD14+ monocytes from JSLE patients depict that monocyte apoptotic mechanisms may be important in lupus pathogenesis.
EmlenWNieburJKaderaR. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol1994; 152: 3685–3692.
2.
RenYTangJMokMYChanAWWuALauCS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum2003; 48: 2888–2897.
3.
HermannMVollREZollerOMHagenhoferMPonnerBBKaldenJR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum1998; 41: 1241–1250.
4.
LiphausBLKissMHBCarrascoSGoldenstein-SchainbergC. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus. J Rheumatol2007; 34: 1580–1584.
5.
LiphausBLKissMHBCarrascoSGoldenstein-SchainbergC. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis. Clin Dev Immunol2006; 13: 283–287.
6.
BijlMReefmanEHorstGLimburgPCKallenbergCG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: Correlates with decreased serum levels of complement. Ann Rheum Dis2006; 65: 57–63.
7.
Carneiro-SampaioMLiphausBLJesusAASilvaCAOliveiraJBKissMH. Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies. J Clin Immunol2008; 28: 34–41.
8.
ShoshanYShapiraIToubiEFrolkisIYaronMMevorachD. Accelerated Fas‐mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: Relevance to in vitro impairment of interaction with iC3b‐opsonized apoptotic cells. J Immunol2001; 167: 5963–5969.
9.
KahnPJZhangHZLevyDImundoLEichenfieldAWinchestetR. Monocytes in the urine of children with lupus: A potential marker of active nephritis. Arthritis Rheum2008; 58: S228–S228.
10.
HeidenreichS. Monocyte CD14: A multifunctional receptor engaged in apoptosis from both sides. J Leukoc Biol1999; 65: 737–743.
11.
BasSGauthierBRSpenatoUStingelinSGabayC. CD14 is an acute‐phase protein. J Immunol2004; 172: 4470–4479.
12.
SakataKMSakataALongLVela‐RochNTalalNDangH. Monocyte rescue of human T cells from apoptosis is CD40/CD154 dependent. Scand J Immunol1999; 50: 479–484.
13.
DevittAMoffattODRaykundaliaCCapraJDSimmonsDLGregoryCD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature1998; 392: 505–509.
14.
Antal‐SzalmásPSzöllosiILakosG. A novel flow cytometric assay to quantify soluble CD14 concentration in human serum. Cytometry2001; 45: 115–123.
15.
KitchensRLThompsonPA. Modulatory effects of sCD14 and LBP on LPS‐host cell interactions. J End Res2005; 11: 225–229.
16.
Rey NoresJEBensussanAVitaN. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol1999; 29: 265–276.
17.
AriasMARey NoresJEVitaN. Cutting edge: Human B cell function is regulated by interaction with soluble CD14: Opposite effects on IgG1 and IgE production. J Immunol2000; 164: 3480–3485.
18.
KaplanMJLewisEESheldenEA. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J Immunol2002; 169: 6020–6029.
19.
RichardsonBCYungRLJohnsonKJRowsePELalwaniND. Monocyte apoptosis in patients with active lupus. Arthritis Rheum1996; 39: 1432–1434.
20.
NockherWAWigandRSchoeppeWScherberichJE. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol1994; 96: 15–19.
21.
EgererKFeistERohrUPrussABurmesterGRDörnerT. Increased serum soluble CD14, ICAM‐1 and E‐selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus2000; 9: 614–621.
22.
YuSNakashimaNXuBH. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: In the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatol Int1998; 17: 237–243.
23.
TakeshitaSNakataniKTsujimotoHKawamuraYKawaseHSekineI. Increased levels of circulating soluble CD14 in Kawasaki disease. Clin Exp Immunol2000; 119: 376–381.
24.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of SLE. Arthritis Rheum1982; 25: 1271–1277.
25.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum1997; 40: 1725–1725.
26.
BombardierCGladmanDDUrowitzMBCaronDChangCH. Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum1992; 35: 630–640.
27.
MartiGESteler‐StevensonMBleesingJJFleisherTA. Introduction to flow cytometry. Semin Hematol2001; 38: 93–99.
28.
RosnerB. Fundamentals of biostatistics, 5th ed. Pacific Grove, CA: Duxbury Thompson Learning, 2000.
29.
LilesWCKienerPALedbetterJAAruffoAKlebanoffSJ. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med1996; 184: 429–440.
30.
KienerPADavisPMStarlingGC. Differential induction of apoptosis by Fas‐Fas ligand interactions in human monocytes and macrophages. J Exp Med1997; 185: 1511–1516.
31.
UmHDOrensteiJMWahlSM. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol1996; 156: 3469–3477.
32.
IwaiKMiyawakiTTakizawaT. Differential expression of Bcl‐2 and susceptibility to anti‐Fas‐mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood1994; 84: 1201–1208.
33.
RichardsonBCStrahlerJRPivirottoTSQuddusJBaylissGE. Phenotypic and functional similarities between 5‐azacytidine‐treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum1992; 35: 647–662.
34.
BengtssonAAGullstrandBTruedssonLSturfeltG. SLE serum classical caspase‐dependent apoptosis independent of death receptor. Clin Immunol2008; 126: 57–66.
35.
LorenzHMGrünkeMHieronymusT. In vitro apoptosis and expression of apoptosis‐related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum1997; 40: 306‐317–306‐317.
36.
EneslättKRantapää-DahlqvistSUddhammarASundqvistKG. The regulation of FasL expression—a distinguishing feature between monocytes and T lymphocytes/NK cells with possible implications for SLE. J Clin Immunol2001; 21: 183–192.
37.
DiekerJWvan der VlagJBerdenJH. Deranged removal of apoptotic cells: Its role in the genesis of lupus. Nephrol Dial Transpl2004; 19: 282–285.
38.
ScottRSMcMahonEJPopSM. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature2001; 411: 207–211.
39.
SteinbachFHenkeFKrauseBThieleBBurmesterGRHiepeF. Monocytes from systemic lupus erythematosus patients are severely altered in phenotype and lineage flexibility. Ann Rheum Dis2000; 59: 283–288.
KorbLCAheamJM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited. J Immunol1997; 158: 4525–4528.
42.
JesusAALiphausBLSilvaCAAndradeLECoutinhoACarneiro-SampaioM. Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus. Lupus2011; 20: 1275–1284.
43.
MidgleyAMcLarenZMootsRJEdwardsSWBeresfordMW. The role of neutrophil apoptosis in juvenile‐onset systemic lupus erythematosus. Arthritis Rheum2009; 60: 2390–2401.
44.
KunowaTLeeEG. Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus1998; 7: 597–603.
45.
SümegiAAntal‐SzalmásPAlekszaM. Glucocorticosteroid therapy decreases CD14‐expression and CD14‐mediated LPS‐binding and activation of monocytes in patients suffering from systemic lupus erythematosus. Clin Immunol2005; 117: 271–279.
46.
NockherWAScherberichJE. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoid in vivo and in vitro. J Immunol1997; 158: 1345–1352.
